BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3067785)

  • 1. In vitro and in vivo action of recombinant human GM-CSF (rhGM-CSF) in patients with myelodysplastic syndromes.
    Hoelzer D; Ganser A; Völkers B; Greher J; Walther F
    Blood Cells; 1988; 14(2-3):551-9. PubMed ID: 3067785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I/II study with GM-CSF in patients with myelodysplastic syndromes.
    Hoelzer D; Ganser A; Greher J; Völkers B; Walther F
    Behring Inst Mitt; 1988 Aug; (83):134-8. PubMed ID: 3071328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
    Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
    Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase-I/II trial.
    Ganser A; Völkers B; Greher J; Walther F; Hoelzer D
    Onkologie; 1988 Feb; 11(1):53-5. PubMed ID: 3283627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
    Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
    N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome.
    Herrmann F; Mertelsmann R; Lindemann A; Ottmann OG; Seipelt G; Oster W; Hoelzer D; Ganser A
    Biotechnol Ther; 1991; 2(3-4):299-311. PubMed ID: 1845132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast-expressed granulocyte-macrophage colony-stimulating factor in cancer patients: a phase ib clinical study.
    Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R
    Behring Inst Mitt; 1988 Aug; (83):107-18. PubMed ID: 2467645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
    Rifkin RM; Hersh EM; Salmon SE
    Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of recombinant DNA granulocyte macrophage colony stimulating factor.
    Steward WP; Scarffe JH; Austin R; Crowther D
    Behring Inst Mitt; 1988 Aug; (83):324-6. PubMed ID: 3071348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial.
    Ganser A; Völkers B; Greher J; Ottmann OG; Walther F; Becher R; Bergmann L; Schulz G; Hoelzer D
    Blood; 1989 Jan; 73(1):31-7. PubMed ID: 2642714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of recombinant human granulocyte-macrophage colony-stimulating factor on phagocyte kinetics in man.
    Linch DC; Devereux S; Addison IE
    Behring Inst Mitt; 1988 Aug; (83):320-3. PubMed ID: 3071347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of granulocyte-macrophage colony stimulating factor in patients with HIV infection.
    Mitsuyasu RT; Golde DW
    Behring Inst Mitt; 1988 Aug; (83):139-44. PubMed ID: 3071329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant granulocyte/macrophage-colony stimulating factor in human and murine bone marrow transplantation.
    Blazar BR; Widmer MB; Kersey JH; Ramsay NK; McGlave PB; Urdal DL; Gillis S; Henney C; Vallera DA
    Behring Inst Mitt; 1988 Aug; (83):170-80. PubMed ID: 3071335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts.
    Herrmann F; Lindemann A; Klein H; Lübbert M; Schulz G; Mertelsmann R
    Leukemia; 1989 May; 3(5):335-8. PubMed ID: 2654495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure.
    Shadduck RK; Rosenfeld CS; Sulecki M; Phillips N; Przepiorka D; Earle M; Stoller R; Jacobs S
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():303-12; discussion 312-3. PubMed ID: 2182742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
    Geissler D; Niederwieser D; Aulitzky WE; Tilg H; Grünewald K; Huber C; Konwalinka G
    Behring Inst Mitt; 1988 Aug; (83):289-300. PubMed ID: 3071343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-dose chemoradiotherapy combined with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by autologous peripheral blood stem cell transplantation (PBSCT) in a case of refractory acute myelogenous leukemia (AML)].
    Tanosaki R; Okamoto S; Takahashi S; Inoue T; Kikuno K; Aoki Y; Takada M; Irie S; Shimane M; Tojo A
    Rinsho Ketsueki; 1993 Aug; 34(8):946-51. PubMed ID: 8105115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.